107 related articles for article (PubMed ID: 1357101)
1. 3-[(+-)-2-carboxypiperazin-4-yl]propyl-1-phosphonic acid recognizes two N-methyl-D-aspartate binding sites in rat cerebral cortex membranes.
van Amsterdam FT; Giberti A; Mugnaini M; Ratti E
J Neurochem; 1992 Nov; 59(5):1850-5. PubMed ID: 1357101
[TBL] [Abstract][Full Text] [Related]
2. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.
Mugnaini M; Antolini M; Corsi M; van Amsterdam FT
J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880
[TBL] [Abstract][Full Text] [Related]
3. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
4. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
[TBL] [Abstract][Full Text] [Related]
5. Modulation of [3H]3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP) binding by ligands acting at the glycine and the polyamine sites of the rat brain NMDA receptor complex.
Porter RH; Briggs RS; Roberts PJ
Eur J Pharmacol; 1992 Sep; 227(1):83-8. PubMed ID: 1426025
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of NMDA receptors labelled with [3H]3-((+-)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains.
Porter RH; Cowburn RF; Alasuzoff I; Briggs RS; Roberts PJ
Eur J Pharmacol; 1992 Mar; 225(3):195-201. PubMed ID: 1387617
[TBL] [Abstract][Full Text] [Related]
7. Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding.
Samuel D; Errami M; Nieoullon A
J Neurochem; 1990 Jun; 54(6):1926-33. PubMed ID: 2159977
[TBL] [Abstract][Full Text] [Related]
8. Radioligand labeling of N-methyl-D-aspartic acid (NMDA) receptors by [3H](+-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in brain synaptic membranes treated with Triton X-100.
Yoneda Y; Ogita K; Kouda T; Ogawa Y
Biochem Pharmacol; 1990 Jan; 39(1):225-8. PubMed ID: 2153381
[No Abstract] [Full Text] [Related]
9. N-methyl-D-aspartate receptors in the retina: 3-[(+/-)-2-carboxypiperazin- 4-yl]-propyl-1-phosphonic acid (CPP) binding studies.
López-Colomé AM; Somohano F
Neuropharmacology; 1992 Jun; 31(6):577-84. PubMed ID: 1407397
[TBL] [Abstract][Full Text] [Related]
10. Solubilization and partial purification of 3-((+-)-2-carboxypiperazine-4-yl)-[1,2-3H]propyl-1-phosphonic acid recognition proteins from rat brain synaptic membranes.
Cunningham MD; Michaelis EK
J Biol Chem; 1990 May; 265(14):7768-78. PubMed ID: 1970819
[TBL] [Abstract][Full Text] [Related]
11. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
Baron BM; Dudley MW; McCarty DR; Miller FP; Reynolds IJ; Schmidt CJ
J Pharmacol Exp Ther; 1989 Jul; 250(1):162-9. PubMed ID: 2545857
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on binding of 3 different ligands to the N-methyl-D-aspartate recognition domain in brain synaptic membranes treated with Triton X-100.
Zuo P; Ogita K; Han D; Yoneda Y
Brain Res; 1993 Apr; 609(1-2):253-61. PubMed ID: 8099522
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
[TBL] [Abstract][Full Text] [Related]
14. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
[TBL] [Abstract][Full Text] [Related]
15. Glutamate receptor changes in brain synaptic membranes from human alcoholics.
Michaelis EK; Freed WJ; Galton N; Foye J; Michaelis ML; Phillips I; Kleinman JE
Neurochem Res; 1990 Nov; 15(11):1055-63. PubMed ID: 1982456
[TBL] [Abstract][Full Text] [Related]
16. Effect of cerebral hypoxia on NMDA receptor binding characteristics after treatment with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) in newborn piglets.
Fritz KI; Groenendaal F; McGowan JE; Mishra OP; Delivoria-Papadopoulos M
Brain Res; 1996 Aug; 729(1):66-74. PubMed ID: 8874877
[TBL] [Abstract][Full Text] [Related]
17. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements.
Grimwood S; Foster AC; Kemp JA
Br J Pharmacol; 1991 Jun; 103(2):1385-92. PubMed ID: 1832067
[TBL] [Abstract][Full Text] [Related]
18. Interactions between the glutamate and glycine recognition sites of the N-methyl-D-aspartate receptor from rat brain, as revealed from radioligand binding studies.
Grimwood S; Wilde GJ; Foster AC
J Neurochem; 1993 May; 60(5):1729-38. PubMed ID: 8097236
[TBL] [Abstract][Full Text] [Related]
19. Molecular target size analyses of the NMDA-receptor complex in rat cortex.
Honoré T; Drejer J; Nielsen EO; Watkins JC; Olverman HJ; Nielsen M
Eur J Pharmacol; 1989 Aug; 172(3):239-47. PubMed ID: 2550262
[TBL] [Abstract][Full Text] [Related]
20. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
